WNT2B and neoplasm: Extracellular vesicles (EVs) released from uniSTING-treated tumour cells contribute to dendritic cell sensitization, while combination therapy with α-Wnt2b antibodies shows synergistic inhibition of tumour growth and prolonged animal survival (Fig. 8).